Medimix Hematology
  • Home
  • Live from the congress
    • 2026
      • EHA 2026
    • 2025
      • ASH 2025
      • IMS 2025
      • ICML 2025
      • ASCO Chicago 2025
      • EBMT 2025
  • STiP
  • Contact
  • Other specialties
    • Dermatology
    • Oncology
    • Respirology
    • Cardiology
    • Rheumatology
    • Neurology
  • SIGN UP
  • SIGN IN
    • Login
    • Logout
IMS 2026

Home-based treatment in hematology

October 12, 2026

Presented by Dr Jon Tsai (Medical Head Oncology, Northern Europe Sanofi AB, Stockholm, Sweden)

In this video, Dr Jon Tsai, Medical Head for Oncology in Northern Europe at Sanofi, summarizes a study presented at the 2026 Annual Meeting of the International Myeloma Society (IMS) in Glasgow examining home treatment for patients with hematological malignancies in Sweden. The cross-sectional survey, conducted with Swedish academic partners, included 27 responses from nurses across all six healthcare regions.

Of the respondents, 24 (89%) reported to use home-based treatment, most commonly for acute myeloid leukemia, myelodysplastic syndromes, and multiple myeloma. Patient convenience was the primary reason for choosing home-based care. Subcutaneous injections were the most frequently administered treatments, although intravenous therapy was also provided in some cases. Self-administration by patients was relatively common, with medications typically collected from hospital pharmacies.

These findings suggest that home-based treatment is feasible and already widely implemented in Sweden. This approach may become increasingly relevant as the range of therapies suitable for administration outside the hospital setting is expected to expand substantially in the coming years.

Reference:

Tsai J, et al. IMS 2026; Abstract NSP-12.

Back to IMS 2026 overview

Tags:

poster

Share Article

Medimix Hematology

Website created by MediMix © 2026 - Privacy Policy

  • Home
  • Live from the congress
    • 2026
      • EHA 2026
    • 2025
      • ASH 2025
      • IMS 2025
      • ICML 2025
      • ASCO Chicago 2025
      • EBMT 2025
  • STiP
  • Contact
  • Other specialties
    • Dermatology
    • Oncology
    • Respirology
    • Cardiology
    • Rheumatology
    • Neurology
  • SIGN UP
  • SIGN IN
    • Login
    • Logout
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.